
How Pharma Marketers Can Prepare for Trump’s 200% Tariff Threat
Putting aside the politics of this situation for the moment, here are some ways for commercial execs to navigate the current climate of volatility.
Putting aside the politics of this situation for the moment, here are some ways for commercial execs to navigate the current climate of volatility.
The longer we delay, the further we shift costs from polluters to patients — and to every taxpayer who funds Medicare, Medicaid and community hospitals. Environmental stewardship and human health are inseparable; regulating microplastics is preventive medicine on a national scale.
The coming changes in Medicaid will place health plans squarely between a rock and a hard place. Here's how plans are bracing for change.
The bill clarifies very specific patient protections and codifies a Patient’s Bill of Rights, all of which would ensure that individuals receiving supplemental oxygen in the home – and their suppliers – understand requirements around equipment, communications, and care options.
In the race to modernize US healthcare, Donald Trump’s new health data-sharing initiative risks giving Big Tech a stranglehold over patient information, and locking out the very startups that fuel innovation.
We need a national strategy to expand access to palliative care, train the next generation of clinicians, and build the infrastructure that allows for scalable, tech-enabled, patient-centered delivery.
This proposal reflects a broader shift toward more restrictive oversight of inpatient utilization. As CMS finalizes this policy, providers should be aware of the immediate compliance and reimbursement risks associated with the phase-out.
You don’t have to practice in Florida for this law to matter. Patient interest in regenerative care is growing rapidly, and physicians across the country need to be prepared to understand and consider advising patients, where applicable, of these stem cell-related treatment options.
Here's a roadmap that brings together a wide range of existing and new initiatives under four key goals that enable community-based organizations to take stock of their existing capabilities and coordinate across them effectively.
The CMS vision is ambitious, but so is the potential for rehab therapy to shape its execution. To do that, providers must actively engage, document their impact, and advocate for their inclusion in evolving models of care.
As the safety-net landscape shifts and funding uncertainty grows, the path forward is clear. By investing in highly coordinated, data-informed care and aligning health plans, providers and communities around shared goals, we can build a system that reaches individuals with complex care needs, supports whole-person health initiatives and strengthens care across the board.
The goal of the Two-Midnight Rule, originally introduced under traditional Medicare Part A, was to reduce hospital admissions and to ensure the appropriate use of inpatient versus outpatient observation status. Here are some challenges and best practices.
To reduce overdose rates in the U.S., leaders must recognize the impact of medication-assisted treatment in correctional facilities.
State, federal, and academic initiatives have poured time and resources into understanding and addressing these gaps. So why haven’t we made real, lasting progress?
The lessons learned and shared by some of the industry’s leaders are exciting, and some clear opportunities are developing. But under the surface, this year, there is something else, and I’m not sure it’s getting enough attention: anxiety.